Total medical devices industry M&A deals worth $3.2bn were announced globally in May 2021, led by Murano Bidco’s $1.36bn acquisition of Vectura Group, according to GlobalData’s deals database.
Go deeper with GlobalData
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 29.5% over the previous month of $4.48bn and a drop of 49% when compared with the last 12-month average, which stood at $6.19bn.
Comparing M&A deals value in different regions of the globe, Europe held the top position, with total announced deals in the period worth $1.91bn. At the country level, the UK topped the list in terms of deal value at $1.91bn.
In terms of volumes, North America emerged as the top region for medical devices industry M&A deals globally, followed by Europe and then Asia-Pacific.
The top country in terms of M&A deals activity in May 2021 was the US with 20 deals, followed by the UK with five and China with two.
In 2021, as of May, medical devices M&A deals worth $34.74bn were announced globally, marking an increase of 1008.3% year on year.
medical devices industry M&A deals in May 2021: Top deals
The top five M&A deals accounted for 88.03% of the overall value during May 2021.
The combined value of the top five medical devices M&A deals stood at $2.78bn, against the overall value of $3.2bn recorded for the month.
The top five medical devices industry M&A deals of May 2021 tracked by GlobalData were:
1) Murano Bidco’s $1.36bn acquisition of Vectura Group
2) The $550m acquisition of Soliton by Allergan Aesthetics
3) NeoGenomics’ $390m acquisition of Inivata
4) The $260m acquisition of Nexcelom Bioscience by PerkinElmer
5) Roman Health Ventures’ acquisition of Modern Fertility for $225m.
